389 related articles for article (PubMed ID: 19874859)
21. Synthesis of blue luminescent si nanoparticles using atmospheric-pressure microdischarges.
Sankaran RM; Holunga D; Flagan RC; Giapis KP
Nano Lett; 2005 Mar; 5(3):537-41. PubMed ID: 15755110
[TBL] [Abstract][Full Text] [Related]
22. Proteomic analysis of serum opsonins impacting biodistribution and cellular association of porous silicon microparticles.
Serda RE; Blanco E; Mack A; Stafford SJ; Amra S; Li Q; van de Ven A; Tanaka T; Torchilin VP; Wiktorowicz JE; Ferrari M
Mol Imaging; 2011 Feb; 10(1):43-55. PubMed ID: 21303614
[TBL] [Abstract][Full Text] [Related]
23. Particle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors.
Wang Z; Wu Z; Liu J; Zhang W
Expert Opin Drug Deliv; 2018 Apr; 15(4):379-395. PubMed ID: 29264946
[TBL] [Abstract][Full Text] [Related]
24. The hydrogel template method for fabrication of homogeneous nano/microparticles.
Acharya G; Shin CS; McDermott M; Mishra H; Park H; Kwon IC; Park K
J Control Release; 2010 Feb; 141(3):314-9. PubMed ID: 19822178
[TBL] [Abstract][Full Text] [Related]
25. PLGA nano/microparticles loaded with cresyl violet as a tracer for drug delivery: Characterization and in-situ hyperspectral fluorescence and 2-photon localization.
Lunardi CN; Gomes AJ; Palepu S; Galwaduge PT; Hillman EM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):505-511. PubMed ID: 27770922
[TBL] [Abstract][Full Text] [Related]
26. Light scattering of ultrafine silica particles by VUV synchrotron radiation.
Shu J; Wilson KR; Arrowsmith AN; Ahmed M; Leone SR
Nano Lett; 2005 Jun; 5(6):1009-15. PubMed ID: 15943434
[TBL] [Abstract][Full Text] [Related]
27. Biodistribution and Excretion of Intravenously Injected Mesoporous Silica Nanoparticles: Implications for Drug Delivery Efficiency and Safety.
Lindén M
Enzymes; 2018; 43():155-180. PubMed ID: 30244806
[TBL] [Abstract][Full Text] [Related]
28. An integrated approach for the rational design of nanovectors for biomedical imaging and therapy.
Godin B; Driessen WH; Proneth B; Lee SY; Srinivasan S; Rumbaut R; Arap W; Pasqualini R; Ferrari M; Decuzzi P
Adv Genet; 2010; 69():31-64. PubMed ID: 20807601
[TBL] [Abstract][Full Text] [Related]
29. In vivo evaluation of vascular-targeted spheroidal microparticles for imaging and drug delivery application in atherosclerosis.
Namdee K; Thompson AJ; Golinski A; Mocherla S; Bouis D; Eniola-Adefeso O
Atherosclerosis; 2014 Nov; 237(1):279-86. PubMed ID: 25286447
[TBL] [Abstract][Full Text] [Related]
30. Controlling metal nanotoppings on the tip of silicide nanostructures.
Hwang IC; Kumar R; Kim ND; Chun Y; Lee JW; Kumar P; Mana RS; Choi C; Lee JR; Kim KS
Nanotechnology; 2009 Jun; 20(24):245605. PubMed ID: 19471081
[TBL] [Abstract][Full Text] [Related]
31. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles.
Banerjee T; Mitra S; Kumar Singh A; Kumar Sharma R; Maitra A
Int J Pharm; 2002 Aug; 243(1-2):93-105. PubMed ID: 12176298
[TBL] [Abstract][Full Text] [Related]
32. Silicon dioxide and titanium dioxide particles found in human tissues.
Peters RJB; Oomen AG; van Bemmel G; van Vliet L; Undas AK; Munniks S; Bleys RLAW; Tromp PC; Brand W; van der Lee M
Nanotoxicology; 2020 Apr; 14(3):420-432. PubMed ID: 31994971
[TBL] [Abstract][Full Text] [Related]
33. Major determinants in hepatic disposition of polystyrene nanospheres: implication for rational design of particulate drug carriers.
Ogawara K; Higaki K; Kimura T
Crit Rev Ther Drug Carrier Syst; 2002; 19(4-5):277-306. PubMed ID: 12661696
[TBL] [Abstract][Full Text] [Related]
34. Morphological control of laser-synthesized silicon nanoparticles.
Hirasawa M; Seto T; Aya N
J Nanosci Nanotechnol; 2001 Dec; 1(4):381-3. PubMed ID: 12914077
[TBL] [Abstract][Full Text] [Related]
35. Discoidal complexes containing apolipoprotein E and their transformation by lecithin-cholesterol acyltransferase.
Gong EL; Nichols AV; Weisgraber KH; Forte TM; Shore VG; Blanche PJ
Biochim Biophys Acta; 1989 Dec; 1006(3):317-28. PubMed ID: 2597674
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of monodisperse core-shell Fe3O4@SiO2 microspheres and its application for magnetic separation of nucleic acids from E. coli BL21.
Ma C; Li C; He N; Wang F; Ma N; Zhang L; Lu Z; Ali Z; Xi Z; Li X; Liang G; Liu H; Deng Y; Xu L; Wang Z
J Biomed Nanotechnol; 2012 Dec; 8(6):1000-5. PubMed ID: 23030008
[TBL] [Abstract][Full Text] [Related]
37. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles.
Cho M; Cho WS; Choi M; Kim SJ; Han BS; Kim SH; Kim HO; Sheen YY; Jeong J
Toxicol Lett; 2009 Sep; 189(3):177-83. PubMed ID: 19397964
[TBL] [Abstract][Full Text] [Related]
38. Programmable fluidic production of microparticles with configurable anisotropy.
Sung KE; Vanapalli SA; Mukhija D; McKay HA; Millunchick JM; Burns MA; Solomon MJ
J Am Chem Soc; 2008 Jan; 130(4):1335-40. PubMed ID: 18166053
[TBL] [Abstract][Full Text] [Related]
39. Observation of assembly of fluorescent Si nanoparticles under the influence of electric current.
Smith A; Chaieb S; al Aql A; Alsalhi M; Nayfeh MH
J Nanosci Nanotechnol; 2002 Oct; 2(5):471-3. PubMed ID: 12908281
[TBL] [Abstract][Full Text] [Related]
40. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
